Late Clinical (Phases II and III)Don’t settle for less. All service labs are not created equally. Myriad RBM specializes in multiplexed protein biomarker assays. We have optimized our service platform to provide you extensive content, better quality data, high throughput, lower sample volume requirements and quick turnaround time – all at a lower price. We have a strategic partnership with Covance and are proud to be a part of their Biomarker Center of Excellence. Contact your local Myriad RBM sales representative to learn how to include Myriad RBM in your next RFP.
|
|
Trust the data. We don’t just run kits – we develop, manufacture and validate our multiplexed assays to clinical laboratory standards. With Myriad RBM, you can move forward knowing that the data generated is sensitive, reliable and reproducible. We operate a CLIA-certified lab and can support GLP studies. Please see our 
Rely on our expertise. We’ve been doing this for over a decade, combining multiplex immunoassay technology with liquid handling automation and a clinical lab infrastructure to quickly deliver sensitive, reproducible results. Our platform provides cost-effective data supporting research at each stage of drug development. We can identify new biomarkers linked to your disease indication or the efficacy of your drug and we can provide testing services for those biomarkers throughout the development process. We also have biomarker panels with specific applications, such as KidneyMAP® for early detection of renal toxicity. Visit our 
